From: Genes and signaling pathways involved in memory enhancement in mutant mice
Mutant | Memory phenotypes | LTP phenotypes | References |
---|---|---|---|
Excitatory synaptic transmission | |||
NR2B (GluN2B) Tg | Enhanced in MWM, CFC, ORT, NMT | Enhanced CA1 LTP | |
Cdk5 cKO | Enhanced in CFC, reversal learning in MWM | Enhanced CA1 LTP | [5] |
p25 Tg | Enhanced in MWM, CFC | Enhanced CA1 LTP | [6] |
Kif17 Tg | Enhanced in MWM, DMT | Not determined | [7] |
ORL1 KO | Enhanced in MWM, CFC, PA | Enhanced CA1 LTP | |
Hgf Tg | Enhanced in MWM | Not determined | [10] |
Ca v β3 KO | Enhanced in MWM | Enhanced CA1 LTP | [11] |
Dao KO | Enhanced in MWM | Enhanced CA1 LTP | [12] |
Presynaptic function | Â | Â | Â |
H-ras Tg | Enhanced in MWM, CFC | Enhanced CA1, cortical LTP | [13] |
Ncx2 KO | Enhanced in MWM, CFC, ORT | Enhanced CA1 LTP | [14] |
Cbl-b KO | Enhanced in MWM (remote memory) | No change in CA1 LTP | [15] |
Gap43 Tg | Enhanced in MWM | Enhanced CA1 LTP | [16] |
Inhibitory synaptic transmission | |||
GABA A R α4 (Gabra4) KO | Enhanced in CFC, TFC | Not determined | [17] |
Magl KO | Enhanced in MWM, ORT | Enhanced CA1 LTP | [18] |
Pkr (Eif2ak2) KO | Enhanced in MWM, CFC, AFC | Enhanced CA1 LTP | [19] |
GABA A R α5 (Gabra5) KO | Enhanced in MWM | Trend of enhanced CA1 LTP | [20] |
Grpr KO | Enhanced in CFC, AFC | Enhanced amygdala LTP | [21] |
Network activity | Â | Â | Â |
Bec1 KO | Enhanced in MWM, YM | No change in CA1 LTP; Impaired LTP in Tg | [22] |
Kvβ1.1 KO | Enhanced in MWM (aged mice only) | Enhanced CA1 LTP (aged mice only) | [23] |
Hcn1 KO | Enhanced in MWM | Enhanced perforant path LTP | [24] |
Transcriptional regulation and its upstream molecules | |||
CREB-Y134F Tg | Enhanced in MWM, CFC, SR, CD | Enhanced CA1 LTP | [25] |
CREB-DIEDML Tg | Enhanced in CFC, SR | Not determined | [25] |
eIF2αS51A KI | Enhanced in MWM, CFC, AFC | Enhanced CA1 LTP | [26] |
Gcn2 KO | Enhanced in MWM, impaired in CFC | Enhanced CA1 LTP | [27] |
ATF4, C/EBP CI | Enhanced in MWM | Enhanced CA1 LTP | [28] |
CamkIV Tg | Enhanced in CFC | Enhanced CA1 LTP | [29] |
Ac1 Tg | Enhanced in ORT | Enhanced CA1 LTP | [30] |
Ap oa 1 Tg | Enhanced in CFC, ORT | Enhanced CA1 LTP | [31] |
Pde4d KO | Enhanced in MWM, RAM, ORT | Not determined, but see[32] | [33] |
Pde8b KO | Enhanced in MWM, CFC | Not determined | [34] |
Calcineurin CI | Enhanced in MWM, AFC, ORT | Enhanced CA1 LTP | |
PP1 CI | Enhanced in MWM, ORT | Enhanced CA1 LTP | |
Translational regulation | Â | Â | Â |
Paip2a KO | Enhanced in MWM, OLT, CFC | Enhanced CA1 L-LTP | [39] |
Fkbp12 KO | Enhanced in CFC | Enhanced CA1 L-LTP | [40] |
Epigenetic regulation | Â | Â | Â |
Hdac2 KO | Enhanced in CFC, AFC, NMT | Enhanced CA1 LTP | [41] |
miRNA biogenesis | Â | Â | Â |
Dicer1 KO | Enhanced in MWM, CFC, TFC | Enhanced CA1 LTP | [42] |
Extracellular molecules | Â | Â | Â |
Mmp9 Tg | Enhanced in MWM, ORT | Enhanced CA1 LTP | [43] |
tPA (Plat) Tg | Enhanced in MWM | Enhanced CA1 LTP | [44] |
HB-GAM (Ptn) Tg | Enhanced in MWM | Enhanced CA1 LTP | |
Other manipulations | Â | Â | Â |
Ncs-1 Tg | Enhanced in MWM, ORT | Enhanced perforant path LTP | [47] |
Rgs14 KO | Enhanced in MWM (learning), ORT | Enhanced CA2 LTP | [48] |
5-HT 3 R Tg | Enhanced in CFC | Not determined | [49] |
Maoa KO | Enhanced in CFC, AFC | Not determined | [50] |
Hdc KO | Enhanced in MWM, CFC, AFC | Enhanced CA1 LTP | |
Def45 KO | Enhanced in MWM, ORT | Not determined | |
EC-SOD Tg | Enhanced in MWM, impaired CFC | Enhanced CA1 LTP | [55] |
S100b KO | Enhanced in MWM, CFC | Enhanced CA1 LTP | [56] |